戻る Agenda
CLOSING
Session Chair(s)
Miyoko Yamauchi
Clinical Leader, Specialty Clinical Development Dept., CHUGAI PHARMACEUTICAL CO., LTD., Japan
Speaker(s)
Haruko Yamamoto, MD, PhD
Executive Director, National Cerebral and Cardiovascular Center, Japan